Yeah TLX592 seems OK in that respect though.
Early days but from their proof of concept study recently released;
Initial results demonstrate rapid elimination from blood circulation compared to standard antibodies and hepatic (liver) clearance – both highly desirable characteristics for use with alpha emitting agents.
Yeah TLX592 seems OK in that respect though.Early days but from...
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.60 |
Change
-0.250(5.15%) |
Mkt cap ! $1.433B | |||
| Open | High | Low | Value | Volume |
| $4.84 | $5.02 | $4.30 | $12.45M | 2.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3000 | $4.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.62 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |